Smart-ring maker Oura postponed a planned US stock market flotation worth up to $2.2 billion on 29 September 2026, just hours before its shares were expected to be priced. Its regulatory filings reveal that most of the proposed share sale would have benefited existing investors, while almost all the money going directly to the company had already been earmarked for employee share-award tax obligations.
The maker of the Oura Ring, which monitors measures including sleep and activity, said it was delaying its initial public offering (IPO) because of uncertainty in the market, despite strong demand. Its shares had been expected to start trading on Nasdaq on 30 September under the ticker OURA. The postponement came before that trading could begin. Oura’s 29 September announcement did not set a new listing date.
What was Oura planning to sell?
According to the company’s 21 September filing with the US Securities and Exchange Commission, the flotation was to comprise 50 million shares priced between $40 and $44 each. At the middle of that range, $42, the total sale would have been worth approximately $2.1 billion. At the top end, it would have raised $2.2 billion.
That total was the value of the shares being offered, not the amount Oura itself would have received. The distinction is central to understanding the deal.
- 36.5 million shares (73%) were to be sold by existing shareholders. Oura would not receive the proceeds of those sales.
- 13.5 million shares (27%) were new shares being sold by Oura, potentially bringing the company $567 million before underwriting and other offering costs.
The indicative valuation also depended on the measure used. At the $42 midpoint, the proposed deal implied a market capitalisation of about $13.5 billion; a fully diluted valuation, which allows for additional shares and share awards, was higher.
Where was the company’s money going?
The most striking figure appears in the SEC filing’s “Use of Proceeds” section. Oura estimated it would receive about $532.6 million net from its own new-share sale at the proposed $42 price.
Of that, approximately $526.4 million was intended to meet withholding and remittance obligations arising from the settlement of restricted stock units (RSUs), a form of employee share award. On those assumptions, around $6.2 million would have remained for general corporate purposes such as technology, working capital and operating costs.
That is not evidence of wrongdoing. Taxes connected to employee share awards can arise when an IPO allows those awards to vest or settle. But it does mean that, in the proposed transaction, the company’s immediate growth capital was a relatively small part of the headline $2.1 billion figure.
For existing investors, meanwhile, the flotation would have provided a way to sell some or all of their holdings to new public shareholders. The filing explicitly says Oura would receive none of the money from those secondary share sales.
Why postpone if there was investor demand?
Oura’s official explanation was “uncertainty in the IPO market”. Chief executive Tom Hale said the company had the luxury of choosing its moment, emphasising that the business was profitable and growing.
Reports from Reuters and Axios described a more difficult environment for new stock market listings, with higher bond yields, volatile markets and doubts about technology-company valuations. Axios reported that the offering was around five times oversubscribed, but that interested investors were not necessarily prepared to pay at the top of the proposed share-price range.
That distinction matters. A share sale can attract more orders than shares available and still fall short of the price sellers want. Fortune’s subsequent analysis also examined investor concerns about the proposed valuation and competition from larger wearable-technology businesses. Those are reported market assessments, not reasons independently confirmed by Oura.
Was Oura in financial difficulty?
The available figures do not suggest an immediate business collapse. Oura reported $1.2145 billion in revenue for the nine months to 30 June 2026, up 74% from the equivalent period a year earlier. It also reported $60.8 million in net income over those nine months, compared with $1.6 million a year before.
In its postponement statement, Oura said its paid membership had reached 5.7 million following the Oura Ring 5 launch and forecast revenue growth of 90% for its financial year ending in September. The growth forecast was the company’s projection, not a final audited result.
There were nevertheless risks for prospective investors to consider. The SEC filing disclosed an August 2026 class action alleging misleading claims about sleep-tracking accuracy. The allegations are not established findings. Oura did not identify that lawsuit as a reason for postponing the IPO, and there is no demonstrated causal link between the two events.
What remains unknown?
As at 31 October 2026, Oura had not announced a confirmed new IPO date. The company has not publicly established how much of the postponement was attributable to its preferred valuation, wider financial-market conditions or other considerations.
The proposed price range and amounts in the filing were estimates for a transaction that did not go ahead. If Oura returns to the market, the share split, pricing and intended use of proceeds could change.
The broader lesson is that the size of an IPO does not tell readers how much new funding a company will actually receive. To answer that question, it is necessary to look at who is selling the shares and what the issuer says it plans to do with its proceeds.
Sources and documents
- US SEC: Oura amended Form S-1 prospectus, 21 September 2026
- Oura: statement postponing the IPO, 29 September 2026
- Reuters: US IPO postponement and market conditions, 29 September 2026
- Axios: investor demand and reported pricing concerns, 29 September 2026
- Fortune: analysis of valuation concerns, 6 October 2026
